Viral Protease Inhibitors

All categories
DBCAT005553Pharmacologic class

Compounds that specifically inhibit PROTEOLYTIC ENZYMES that are encoded by VIRUSES. A DrugBank category of 11 drugs. 11 of them are approved.

Drugs

What you can answer from here — as of January 08, 2022

11DrugsEach linked to its full drug card
Listed above
12Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1,170Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Viral Protease Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In